Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'mk 0773'

Search results for: 'mk 0773'

Items 1-10 of 14

Page
per page
  1. MK 0893
    A3608 MK 0893
    Target: Insulin and Insulin-like Receptors|Glucagon Receptors
    Summary: Glucagon receptor/IGF-1R antagonist
      ≥24.05 mg/mL
  2. MK-2206 dihydrochloride
    A3010 MK-2206 dihydrochloride
     21 Citation
    Target: Akt
    Summary: Akt1/2/3 inhibitor
      insoluble in EtOH; ≥12.01 mg/mL
  3. MK-4827
    A3617 MK-4827
    Target: PARP
    Summary: PARP-1/-2 inhibitor,potent and selective
      ≥32 mg/mL
  4. MK-8745
    A8807 MK-8745
    Target: Aurora Kinases
    Summary: Aurora A inhibitor,potent and selective
      ≥21.6 mg/mL
  5. MK-2461
    A8476 MK-2461
    Target: FLT3|PDGFR|MET|Ron
    Summary: C-Met (WT/mutants) inhibitor
      ≥24.8 mg/mL
  6. MK-571
    B7023 MK-571
    Target: Leukotriene and Related Receptors
    Summary: leukotriene D4 receptor antagonist, orally active
      ≥55.1 mg/mL
  7. (-)-MK 801
    B1627 (-)-MK 801
    Target: NMDA Receptors
    Summary: NMDA antagonist,potent and selective
      insoluble in H2O; ≥10.3 mg/mL
  8. Odanacatib (MK-0822)
    A2487 Odanacatib (MK-0822)
    Target: Cathepsins
    Summary: Cathepsin K,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥17.7 mg/mL
  9. Raltegravir (MK-0518)
    A4073 Raltegravir (MK-0518)
     1 Citation
    Target: integrase
    Summary: HIV-1 integrase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.95 mg/mL
  10. VX-680 (MK-0457,Tozasertib)
    A4111 VX-680 (MK-0457,Tozasertib)
    Target: Aurora Kinases
    Summary: Aurora kinase inhibitor
      ≥23.25 mg/mL

Items 1-10 of 14

Page
per page